We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A possible case of serum sickness after ocrelizumab infusion – Commentary.
- Authors
Al-Araji, Sarmad; Ciccarelli, Olga
- Abstract
Serum sickness is a type III delayed hypersensitivity reaction which causes deposition of immune-complexes in the tissues. It has been reported with rituximab, and in this issue of the journal, there is a case report of a patient with relapsing remitting multiple sclerosis who developed a possible serum sickness after the third infusion of ocrelizumab. In this commentary, we discuss the current literature on serum sickness, and how to diagnose and manage it. We provide our opinion on this particular case, and encourage neurologists and patients to remain vigilant of such a possibility.
- Subjects
DISEASES; SERUM; DELAYED hypersensitivity; DISEASE relapse; MULTIPLE sclerosis
- Publication
Multiple Sclerosis Journal, 2021, Vol 27, Issue 1, p158
- ISSN
1352-4585
- Publication type
Article
- DOI
10.1177/1352458520923947